The physical and psychological impact of neurogenic claudication: the patients’ perspectives

Carlo Ammendolia; Michael Schneider; Kelly Williams; Susan Zickmund; Megan Hamm; Kent Stuber; Christy Tomkins-Lane; Y Raja Rampersaud

Table 2.

Comparison of non-surgical and surgical clinic participants

Mean (SD) Mean Usual overall NPS (0–10) Mean SSS Symptoms (1–5) Mean SSS Function (1–4) Mean ODI (0–100) Mean ODI Walk (1–5) Mean Usual Interference with activity (0–10) Duration of symptoms impacting walk/stand Years n, %
Non-surgical clinic n=16 5.2 (2.8) 2.9 (0.6) 2.0 (0.7) 37.6 (14.8) 2.8 (1.8) 4.6 (4.1) 0–1
1–5
5+ 2, 12.5%
8, 50.0%
6, 37.5%
Surgical clinic n=12 4.9 (3.1) 2.7 (0.8) 2.3 (0.8) 43.7 (19.3) 3.0 (2.0) 5.1 (3.9) 0–1
1–5
5+ 2, 16.7%
3, 25.0%
7, 58.3%
All participants n= 28 26 28 28 28 28 26 28
p-value (from T-test or Chi-square) 0.82 0.33 0.25 0.36 0.79 0.78 0.40

Legend:
NPS= numeric pain scale (higher score worse pain), SSS= Spinal Stenosis Score (higher score worst symptoms/function), ODI– Oswestry Disability Index (higher score worst disability/walk ability), SD= Standard Deviation

Mean (SD)	Mean Usual overall NPS (0–10)	Mean SSS Symptoms (1–5)	Mean SSS Function (1–4)	Mean ODI (0–100)	Mean ODI Walk (1–5)	Mean Usual Interference with activity (0–10)	Duration of symptoms impacting walk/stand Years n, %
Non-surgical clinic n=16	5.2 (2.8)	2.9 (0.6)	2.0 (0.7)	37.6 (14.8)	2.8 (1.8)	4.6 (4.1)	0–1 1–5 5+	2, 12.5% 8, 50.0% 6, 37.5%
Surgical clinic n=12	4.9 (3.1)	2.7 (0.8)	2.3 (0.8)	43.7 (19.3)	3.0 (2.0)	5.1 (3.9)	0–1 1–5 5+	2, 16.7% 3, 25.0% 7, 58.3%
All participants n= 28	26	28	28	28	28	26	28
p-value (from T-test or Chi-square)	0.82	0.33	0.25	0.36	0.79	0.78	0.40